Logan Coy Related postsA Protocol to Assess the Safety, Efficacy, and Pharmacokinetics of Continuous Subcutaneous Low-Dose Lenalidomide (STAR-LLD) for the Treatment of Multiple MyelomaSeptember 11, 2026A Study Assessing KB707 for the Treatment of Advanced Solid Tumor Malignancies Affecting the LungsSeptember 11, 2026Substudy ASPEN-09-03: A Single-arm Phase 2 Study of Evorpacept with Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer (ASPEN-09-03), Protocol AT148009September 10, 2026 Previous postA Phase 1 Dose Escalation Study of the Tolerability, Safety, Efficacy and Pharmacokinetics of ZG006 in Small Cell Lung CancerNext postAn Open-Label, Randomized, Controlled Phase 3 Study of Sigvotatug Vedotin with Pembrolizumab vs Pembrolizumab Monotherapy as First-Line Treatment in PD-L1 High Advanced NSCLC (BE6A LUNG-02)